| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 04/22/2010 | CA2725383A1 Smallpox dna vaccine and the antigens therein that elicit an immune response |
| 04/21/2010 | EP2177619A1 HSV strains for the oncolytic treatment of cancer |
| 04/21/2010 | EP2177535A1 Antibody having inhibitory activity on infection with hepatitis c virus (hcv), and use thereof |
| 04/21/2010 | EP2177534A2 Heteroclitic analogs of class i epitopes |
| 04/21/2010 | EP2177530A1 Octapeptide having antiangiogenic activity |
| 04/21/2010 | EP2177527A1 2'-fluoro-4'-substituted nucleosides, the preparation and use |
| 04/21/2010 | EP2177526A1 10a-azalide compound crosslinked at position-10a and position-12 |
| 04/21/2010 | EP2177523A1 Novel macrocyclic inhibitors of hepatitis c virus replication |
| 04/21/2010 | EP2177522A1 Novel carbapenem derivatives |
| 04/21/2010 | EP2177511A2 Process for preparing 3,6-disubstituted azabicyclo derivatives |
| 04/21/2010 | EP2177214A1 Solid Oral Dosage Forms and Uses |
| 04/21/2010 | EP2177209A1 Intravenous solutions and uses |
| 04/21/2010 | EP2176276A2 Derivatives of nystatin and their use as antifungal agents |
| 04/21/2010 | EP2176275A1 Adefovir dipivoxil crystalline monohydrate form |
| 04/21/2010 | EP2176262A1 Tricyclic compounds as antibacterials |
| 04/21/2010 | EP2176255A1 Andrographolide derivatives and use thereof in manufacture of medicaments |
| 04/21/2010 | EP2176248A1 New antimicrobial compounds, their synthesis and their use for treatment of mammalian infections |
| 04/21/2010 | EP2176218A2 Stereoisomers of tricyclodecan-9-yl-xanthogenate |
| 04/21/2010 | EP2176211A1 Organic compounds |
| 04/21/2010 | EP2175865A2 Controlled release interferon drug products and treatment of hcv infection using same |
| 04/21/2010 | EP2175864A2 Use of hydrolytic and oxidative enzymes to dissolve biofilm in airway passages |
| 04/21/2010 | EP2175857A2 Crystalline form of (e) 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile |
| 04/21/2010 | EP1963324B1 Heterocyclic compounds, their preparation and their use as antibacterials |
| 04/21/2010 | EP1819728B1 Il-7 variants with reduced immunogenicity |
| 04/21/2010 | EP1471887B1 Nanoparticulate compositions having lysozyme as a surface stabilizer |
| 04/21/2010 | EP1323730B1 Novel polypeptides and anti-hiv drugs containing the same |
| 04/21/2010 | EP1272175B1 N,n'-diaryl guanidines as il-8 receptor antagonists |
| 04/21/2010 | EP1231930B1 HUMAN IgM ANTIBODIES TO CHEMOKINE RECEPTORS |
| 04/21/2010 | CN1977852B Medicinal composition containing stilbene total glycoside and its use for pharmaceutical treating hepatitis B |
| 04/21/2010 | CN1947750B Traditional Chinese medicine for treating newcastle disease |
| 04/21/2010 | CN1927250B Pharmaceutical composition, its preparation method and application |
| 04/21/2010 | CN1887351B Hepatitis B preventing vaccine and its preparation method |
| 04/21/2010 | CN1883275B A botanical antibiotic and application thereof |
| 04/21/2010 | CN1879727B Novel hepatitis B inhibitor and application thereof |
| 04/21/2010 | CN1843507B Mumps virus ingredient vaccine for human, and its preparation method and uses |
| 04/21/2010 | CN1819990B Compound having anti-HCV activity and process for producing the same |
| 04/21/2010 | CN1740169B Arylmethylamine derivatives for use as tryptase inhibitors |
| 04/21/2010 | CN1711096B Botulinum toxin formulations for oral administration |
| 04/21/2010 | CN1689628B Medical purpose of creat extract |
| 04/21/2010 | CN1686424B Medicinal composition containing scutellaria and bupleurum and its preparation method |
| 04/21/2010 | CN1639318B Antimicrobial composition |
| 04/21/2010 | CN1343128B Medicinal compositions |
| 04/21/2010 | CN101696399A Porcine reproductive and respiratory syndrome virus M protein CTL cell epitopes and application thereof |
| 04/21/2010 | CN101696242A Human anti rabies virus neutralizing antibody Fab as well as preparation method and application thereof |
| 04/21/2010 | CN101696232A Peptidomimetic protease inhibitors |
| 04/21/2010 | CN101696214A Cefminox sodium compound of new route |
| 04/21/2010 | CN101696211A High-purity sulbactam sodium compound |
| 04/21/2010 | CN101696202A Phenylpropanoid compound contained in rhodiola, preparation method thereof and application thereof |
| 04/21/2010 | CN101695573A Method for producing pseudorabies living vaccines by using subculture cell source and product thereof |
| 04/21/2010 | CN101695572A Method for producing pseudorabies attenuated vaccine by using bioreactor and pseudorabies attenuated vaccine product |
| 04/21/2010 | CN101695571A Method for producing swine fever vaccine by using bioreactor and swine fever vaccine product |
| 04/21/2010 | CN101695570A Univalent and bivalent inactivated vaccine for hand-foot-and-mouth disease and preparation method thereof |
| 04/21/2010 | CN101695569A Univalent and bivalent gene engineered subunit vaccine for hand-foot-and-mouth disease and preparation method thereof |
| 04/21/2010 | CN101695568A A-type clostridium perfringens populus skin lipoid inactivated vaccine and preparation method thereof |
| 04/21/2010 | CN101695567A Water-in-oil type nanoemulsion vaccine preparation |
| 04/21/2010 | CN101695564A Oral liquid for treating verruca vulgaris and preparation method thereof |
| 04/21/2010 | CN101695562A Chinese medicinal composition for treating viral hepatitis and preparation method thereof |
| 04/21/2010 | CN101695550A Pure Chinese medicinal preparation for adjuvant therapy of enteritis type canine parvovirus disease and preparation method thereof |
| 04/21/2010 | CN101695536A Chinese medicinal composition for preventing and treating influenza A virus subtype H1N1 |
| 04/21/2010 | CN101695529A Compound Chinese herbal medicinal preparation for preventing and controlling bacterial enteritis, black gill and red skin disease of freshwater fish |
| 04/21/2010 | CN101695518A Method for extracting total alkaloid of common fibraurea stems, separate fibriuretinin and jatrorrhizine |
| 04/21/2010 | CN101695515A Chinese medicament for treating acquired immune deficiency syndrome and preparation method thereof |
| 04/21/2010 | CN101695512A Banlangen buccal tablet and preparation method thereof |
| 04/21/2010 | CN101695511A Pomegranate rind extract and production method and application thereof |
| 04/21/2010 | CN101695503A Quality control method of pediatric paracetamol, atificial cow-bezoar and chlorphenamine maleate effervescent tablets |
| 04/21/2010 | CN101695494A Composition of cefpriome sulfate and sodium citrate |
| 04/21/2010 | CN101695493A Composition of cefmetazole acid and sodium citrate |
| 04/21/2010 | CN101695490A Medicinal composition for treating livestock and poultry cold, preparation method thereof and application thereof |
| 04/21/2010 | CN101695489A Aztreonam composition, powder injection and preparation method thereof |
| 04/21/2010 | CN101695473A Use and preparation method of vaginal thermosensitive gel |
| 04/21/2010 | CN101695374A Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product |
| 04/21/2010 | CN101390848B Medicine composition azithromycin enteric-coated capsules |
| 04/21/2010 | CN101229343B Chinese traditional medicine for treating pulmonary tuberculosis |
| 04/21/2010 | CN101172161B Water-soluble polymers decorated G-CSF conjugates |
| 04/21/2010 | CN101168029B Method for manufacturing liver-smoothing, qi-regulating and detoxification capsule |
| 04/21/2010 | CN101168000B Method for preparing medicine for treating pulmonary tuberculosis and quality standard detecting method |
| 04/21/2010 | CN101167719B Gallo catechin and gallate microcapsule granule and preparation technique thereof |
| 04/21/2010 | CN101129436B Method of producing dandelion medicinal granules |
| 04/21/2010 | CN101062950B Polyethylene glycol modified thymus peptide 1 derivative |
| 04/21/2010 | CN101041029B Chinese traditional medicine for curing hepatitis B |
| 04/21/2010 | CN101037465B Saponins and preparation method and application |
| 04/21/2010 | CN101028491B Chinese-medicinal preparation for treating ribbon bleb |
| 04/21/2010 | CN100998626B Method for preparing extract of korea thistle leaf |
| 04/20/2010 | US7700765 DNA minor groove binding compounds |
| 04/20/2010 | US7700758 Preparing library of heterogenous small interfering RNA sequences (HSIRNA) for use in gene expression inhibition and mammalian therapeutics; gene therapy |
| 04/20/2010 | US7700755 cytotoxins; host cells; vaccines; histology |
| 04/20/2010 | US7700735 High potency recombinant antibodies and method for producing them |
| 04/20/2010 | US7700657 Vitamin D analogs |
| 04/20/2010 | US7700645 Comprising the ethanolate solvate of Prezista" aka darunavir ethanolate; improved pharmacokinetics;stability; bioavailability; purity; industrial scale; viricides |
| 04/20/2010 | US7700635 Neuroprotectants; treatment of neuropathies resulting from chemtherapeutic agents used in the treatment of HIV and proliferative disease such as cancer and treatment of inflammatory diseases; neurodegenerative diseases; enzyme inhibitorsfor seine/threonine kinases, phosphatases; Alzheimer's |
| 04/20/2010 | US7700617 Salt of naphthyridine carboxylic acid derivative |
| 04/20/2010 | US7700586 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders |
| 04/20/2010 | US7700584 antitumor agents; viricides |
| 04/20/2010 | US7700581 3-((1,2,5,6-tetrahydro-2-methyl-5,6-d ioxo-1,2,4-triazine-3-yl)thio)methyl)-7-[[[[[(1-methyl ethyl)amino][(1-methylethyl)imino]methyl]thio]acetyl]amino]-8-oxo-5-thia-1-aza-bicyclo [4.2.0]oct-2-ene-2-carboxylic acid; bioavailibility; stability; pharmacokinetics; antibiotics; infections |
| 04/20/2010 | US7700577 Bactericides for antibiotic-resistant Micrococcus, Streptococcus, Enterococcus or Staphylococcus; pure saccharide antibiotics; 4-((3-(trifluoromethyl-)phenyl)-amino-carbonylamino-),4,5-(dihydroxy-),6-(hydroxymethyl-)tetrahydropyran-2-yl)-),5-(undecanoylamino-),6-(hydroxymethyl-)tetrahydropyran |
| 04/20/2010 | US7700570 Oligonucleotide mediated specific cytokine induction and prophylaxis and treatment of viral infection in a mammal |
| 04/20/2010 | US7700550 Telavancin or its hydrochloride salt for infection, including MRSA infections; reduced tissue accumulation and/or nephrotoxicity |
| 04/20/2010 | US7700314 Method for producing polyol-IFN-β conjugate |
| 04/20/2010 | US7700133 Antimicrobial formulations and methods of using the same |
| 04/20/2010 | US7700131 Powders having contact biocidal properties |